Following the success of the sell-out Cell Based Assay series, SMi Group has launched its inaugural conference on 3D Cell Culture which takes place on the 22nd and 23rd of February 2017 in London. The agenda, as well as registration, is now live.
With a focus on clinical successes and emerging technologies, the conference will showcase how 3D Cell Culture has revolutionized drug discovery and toxicity screening, as well as how it is emerging as an invaluable tool in stem cell research and regenerative medicine.
The event will also highlight exciting opportunities and latest innovations, spheroid and organoid techniques, as well as key developments in 3D and 4D bio-printing, microfluidics, CRISPR and the ongoing debate of 2D vs 3D cell culture. Expert speakers include AstraZeneca, GSK, Lonza, MHRA, Novartis, Sanofi, etc.